Chimerix Inc (CMRX)
0.9237
+0.01
(+1.36%)
USD |
NASDAQ |
Apr 23, 16:00
0.9237
0.00 (0.00%)
After-Hours: 20:00
Chimerix Debt to Equity Ratio: 0.0006 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0006 |
| September 30, 2023 | 0.0006 |
| June 30, 2023 | 0.0006 |
| March 31, 2023 | 0.0005 |
| December 31, 2022 | 0.001 |
| September 30, 2022 | 0.0009 |
| June 30, 2022 | 0.009 |
| March 31, 2022 | 0.0052 |
| December 31, 2021 | 0.2051 |
| September 30, 2021 | 0.1339 |
| June 30, 2021 | 0.1175 |
| March 31, 2021 | 0.1048 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.001 |
| June 30, 2015 | 0.0037 |
| March 31, 2015 | 0.0112 |
| December 31, 2014 | 0.0156 |
| September 30, 2014 | 0.0322 |
| June 30, 2014 | 0.0372 |
| March 31, 2014 | 0.0946 |
| December 31, 2013 | 0.1001 |
| September 30, 2013 | 0.1076 |
| June 30, 2013 | 0.1144 |
| March 31, 2013 | -6.532 |
| December 31, 2012 | 2.185 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.2051
Maximum
Dec 2021
0.0305
Average
0.0006
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| UFP Technologies Inc | 0.1119 |
| Dentsply Sirona Inc | 0.6432 |
| Arbutus Biopharma Corp | 0.00 |
| Pacira BioSciences Inc | 0.6004 |
| Karyopharm Therapeutics Inc | -1.255 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 212.77M |
| Total Liabilities (Quarterly) | 19.74M |
| Shareholders Equity (Quarterly) | 193.03M |
| Current Ratio | 10.25 |
| Net Debt Paydown Yield | 0.03% |